Bladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report
IJU Case Reports · 2026-11 · 9 (6)
DOI: 10.1002/iju5.70297 ↗Abstract
ABSTRACT Introduction Perivascular epithelioid cell neoplasms originating in the urinary bladder are rare, and their standard treatment methods have not been established. Case Presentation A 14‐year‐old girl with intermittent macroscopic hematuria was referred to our hospital. Ultrasonography and magnetic resonance imaging revealed a 5 cm spherical mass in the bladder neck and transurethral biopsy revealed a perivascular epithelioid cell neoplasm. Chromosome G‐banding analysis indicated a transcription factor E3 gene rearrangement. The mTOR inhibitor, sirolimus, was administered for six months, followed by partial cystectomy. No tumor recurrence was observed after 15 months. Conclusion This case suggests the potential efficacy of partial cystectomy combined with neoadjuvant mTOR inhibitor therapy for transcription factor E3 gene rearrangement‐positive perivascular epithelioid cell neoplasms.
EUVIMED